Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 211 publications
Nivolumab + Doxorubicin, Vinblastine, and Dacarbazine in HIV-Associated Advanced-Stage Classic Hodgkin Lymphoma.
Journal: JCO oncology advances
Published: August 11, 2026
Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826).
Journal: Blood advances
Published: June 10, 2026
A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 26, 2026
Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: May 01, 2026
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 20, 2026
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.
Journal: American journal of clinical pathology
Published: March 14, 2026
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
New Tools and Drugs Improve the Balance Between Cure and Toxicity in Hodgkin Lymphoma.
Journal: Hematology/oncology clinics of North America
Published: February 10, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin.
Journal: Blood cancer journal
Published: February 02, 2026
Last Updated: 09/26/2026